DHG Pharmaceutical JSC 2022 SR
The report highlights DHG Pharma's 2022 performance, achieving its highest revenue and profit in its 48-year history. Key achievements include obtaining Japan-GMP certification for nearly 100 products and commencing construction of a new Betalactam factory meeting international standards. The company committed to environmental sustainability by approving a 2.7 MWp rooftop solar project to reduce carbon emissions. Socially, DHG Pharma provided medical examinations to 21,000 people and maintained its position as a top employer in Vietnam's pharmaceutical industry.
Company: DHG Pharmaceutical JSC
Sector: Health Care
Country: Vietnam
Year: 2022
Type: SR
Pages: 64
DHG Pharmaceutical JSC
Sustainable Development Report
The report highlights DHG Pharma's 2022 performance, achieving its highest revenue and profit in its 48-year history. Key achievements include obtaining Japan-GMP certification for nearly 100 products and commencing construction of a new Betalactam factory meeting international standards. The company committed to environmental sustainability by approving a 2.7 MWp rooftop solar project to reduce carbon emissions. Socially, DHG Pharma provided medical examinations to 21,000 people and maintained its position as a top employer in Vietnam's pharmaceutical industry.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Water Consumption
Women in Management
Workplace Fatalities
Net Zero Target
Employees